Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29. (Q54410290)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29. |
scientific article |
Statements
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29 (English)
S A Laurie
B J Solomon
L Seymour
P M Ellis
G D Goss
F A Shepherd
A M Arnold
P Clingan
F Laberge
D Fenton
V Hirsh
M Zukin
M R Stockler
C W Lee
E X Chen
A Montenegro
K Ding